Microbot to present at inaugural SRS Endovascular Robotics session; FDA 510(k) decision expected this quarter

Microbot Medical Inc.

Participates in Society of Robotic Surgery annual meeting July 16-20 in Strasbourg, France.
CEO Harel Gadot to present overview of endovascular robotics market at panel on July 19.
Company strengthening sales & marketing infrastructure ahead of anticipated U.S. FDA 510(k) decision this quarter.
Liberty system remains investigational; not yet approved for sale in the U.S.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.